XML 32 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
During the three months ended March 31, 2023, the Company paid $62.8 million to repurchase approximately 0.5 million shares of its common stock. As of March 31, 2023, the Board of Directors has authorized the Company to repurchase up to an additional $300.5 million of the Company’s common stock. The repurchase of any or all such shares authorized for repurchase will be governed by applicable SEC rules and dependent on management’s assessment of market conditions and subject to the restrictions on share repurchases set forth in the incremental amendment.
The Company paid a regular cash dividend of $0.65 per share on March 15, 2023 to holders of record at the close of business on March 1, 2023. Cash dividends declared and paid per common share for the three months ended March 31, 2023 and 2022, were as follows: 
 Three months ended March 31,
 20232022
Cash dividends declared and paid per common share$0.65 $0.64 
Net income per share
Basic income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during each period, including shares earned under the Deferred Compensation Plan for Directors (“Director Plan”), the ESOP and deferred stock units under the 2007 Omnibus Incentive Plan (“Omnibus Plan”). Diluted income per share is computed under the treasury stock method and is calculated to compute the dilutive effect of outstanding stock options and certain share-based awards issued under the Omnibus Plan. A reconciliation of these amounts is as follows (in millions):
Three months ended March 31,
20232022
Weighted average number of common shares outstanding 57.0 59.9 
Director Plan and deferred stock units 0.2 0.2 
ESOP 0.2 0.2 
Common shares outstanding—basic 57.4 60.3 
Dilutive effect of restricted stock units0.4 0.5 
Dilutive effect of stock option awards0.3 0.4 
Common and potential common shares outstanding—diluted 58.1 61.2 
During the three months ended March 31, 2023, the number of options that were not included in the computation of diluted income per share because the option exercise price was greater than the market price, and therefore, the effect would have been anti-dilutive was 1.7 million compared to 1.3 million for the same period in 2022.
Accumulated other comprehensive loss
Changes in the accumulated other comprehensive loss balance were as follows (in millions):
Foreign Currency TranslationCash Flow Hedging DerivativesRetirement Plan ActivityAccumulated Other Comprehensive Loss
Balance as of December 31, 2022$(94.8)$10.5 $(3.2)$(87.5)
Reclassification to the statement of income — (6.0)0.1 (5.9)
Change in fair value 14.1 4.6 — 18.7 
Balance as of March 31, 2023$(80.7)$9.1 $(3.1)$(74.7)
See Note 11 for the amount of gains and losses, net of tax, reclassified from accumulated other comprehensive loss into the statements of income for cash flow derivatives designated as hedging instruments.